Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 5
2019 8
2020 19
2021 7
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Oncostatin M: A mysterious cytokine in cancers.
Masjedi A, Hajizadeh F, Beigi Dargani F, Beyzai B, Aksoun M, Hojjat-Farsangi M, Zekiy A, Jadidi-Niaragh F. Masjedi A, et al. Int Immunopharmacol. 2021 Jan;90:107158. doi: 10.1016/j.intimp.2020.107158. Epub 2020 Nov 10. Int Immunopharmacol. 2021. PMID: 33187910 Review.
Adenosine and adenosine receptors in colorectal cancer.
Hajizadeh F, Masjedi A, Heydarzedeh Asl S, Karoon Kiani F, Peydaveisi M, Ghalamfarsa G, Jadidi-Niaragh F, Sevbitov A. Hajizadeh F, et al. Among authors: masjedi a. Int Immunopharmacol. 2020 Oct;87:106853. doi: 10.1016/j.intimp.2020.106853. Epub 2020 Aug 2. Int Immunopharmacol. 2020. PMID: 32755765 Review.
Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.
Hashemi V, Farhadi S, Ghasemi Chaleshtari M, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, Jadidi-Niaragh F. Hashemi V, et al. Among authors: masjedi a. Int Immunopharmacol. 2020 Jun;83:106446. doi: 10.1016/j.intimp.2020.106446. Epub 2020 Mar 31. Int Immunopharmacol. 2020. PMID: 32244048 Review.
CD73 as a potential opportunity for cancer immunotherapy.
Ghalamfarsa G, Kazemi MH, Raoofi Mohseni S, Masjedi A, Hojjat-Farsangi M, Azizi G, Yousefi M, Jadidi-Niaragh F. Ghalamfarsa G, et al. Among authors: masjedi a. Expert Opin Ther Targets. 2019 Feb;23(2):127-142. doi: 10.1080/14728222.2019.1559829. Epub 2018 Dec 26. Expert Opin Ther Targets. 2019. PMID: 30556751 Review.
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MR, Jadidi-Niaragh F. Salimifard S, et al. Among authors: masjedi a. Pathol Res Pract. 2020 May;216(5):152915. doi: 10.1016/j.prp.2020.152915. Epub 2020 Mar 2. Pathol Res Pract. 2020. PMID: 32146002 Review.
Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
Hashemi V, Maleki LA, Esmaily M, Masjedi A, Ghalamfarsa G, Namdar A, Yousefi M, Yousefi B, Jadidi-Niaragh F. Hashemi V, et al. Among authors: masjedi a. Int Immunopharmacol. 2020 Jan;78:106087. doi: 10.1016/j.intimp.2019.106087. Epub 2019 Dec 13. Int Immunopharmacol. 2020. PMID: 31841758 Review.
33 results